UCB's Global Corporate Website
Picture of a financial graph
24 Jul 2024

Half-year results 2024: strong start into UCB’s decade of growth

Read More
16 Jul 2024

Preventing the progression of epileptic seizures and addressing critical treatment gaps

Read More
12 Jul 2024

Advancing Our Gene Therapy Journey

Read More
8 Jul 2024

Leading in healthcare innovation: FASTRAX is on a mission to transform the rheumatic disease journey

Read More
3 Jul 2024

Shaping a better future for women living with epilepsy

Read More
28 Jun 2024

Embracing patient-centered research: the transformative power of partnership

Read More